Navigation Links
Genetic mutation increases risk of Parkinson's disease from pesticides
Date:11/27/2013

Next, they reprogrammed all of these cells to become the specific type of nerve cell that is damaged in Parkinson's disease, called A9 dopamine-containing neuronsthus creating two sets of neuronsidentical in every respect except for the alpha-synuclein mutation.

"Exposing both normal and mutant neurons to pesticidesincluding paraquat, maneb, and rotenonecreated excessive free radicals in cells with the mutation, causing damage to dopamine-containing neurons that led to cell death," said Frank Soldner, M.D., research scientist in Jaenisch's lab and co-author of the study.

"In fact, we observed the detrimental effects of these pesticides with short exposures to doses well below EPA-accepted levels," said Scott Ryan, Ph.D., researcher in the Del E. Webb Center and lead author of the paper.

Having access to genetically matched neurons with the exception of a single mutation simplified the interpretation of the genetic contribution to pesticide-induced neuronal death. In this case, the researchers were able to pinpoint how cells with the mutation, when exposed to pesticides, disrupt a key mitochondrial pathwaycalled MEF2C-PGC1alphathat normally protects neurons that contain dopamine. The free radicals attacked the MEF2C protein, leading to the loss of function of this pathway that would otherwise have protected the nerve cells from the pesticides.

"Once we understood the pathway and the molecules that were altered by the pesticides, we used high-throughput screening to identify molecules that could inhibit the effect of free radicals on the pathway," said Lipton. "One molecule we identified was isoxazole, which protected mutant neurons from cell death induced by the tested pesticides. Since several FDA-approved drugs contain derivatives of isoxazole, our findings may have potential clinical implications for repurposing these drugs to treat Parkinson's."

While the study clearly shows the relationship between a mutation, the env
'/>"/>

Contact: Susan Gammon, Ph.D.
sgammon@sanfordburnham.org
858-795-5012
Sanford-Burnham Medical Research Institute
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Genetics contribute to increased risk for end-stage renal disease for African Americans with CKD
2. Powerful tool for genetic engineering
3. Geneticists receive funding to improve citrus production and health
4. Researchers develop new approach to identify possible ecological effects of releasing genetically engineered insects
5. Potential drug target in sight for rare genetic disease
6. Clinical ovarian cancers display extensive genetic heterogeneity, study suggests multiple treatment
7. Genetic signature identified for RSV, the leading cause of infant hospitalizations worldwide
8. Nurture impacts nature: Experiences leave genetic mark on brain, behavior
9. Cause of genetic disorder found in dark matter of DNA
10. Genetic variation increases risk of kidney disease progression in African-Americans
11. Genetic aberration paves the way for new treatment of cancer disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic mutation increases risk of Parkinson's disease from pesticides
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
(Date:8/5/2015)... 5, 2015 The biosensors market is proving ... penetration into newer sectors, and development of devices resulting ... space has seen the entry of multiple participants each ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... of the Global Biosensors Market ( http://www.frost.com/nee9 ), ...
(Date:7/31/2015)... de 2015 BGI llevará a cabo la 10ª ... al 25 de octubre de 2015, en ... su décimo aniversario este año. Desde su inauguración en ... reuniones anuales más influyentes del mundo en los campos ... científicas más dinámicas, entusiastas y amenas. ICG-10 ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... for a trial to investigate the safety of a ... Allergy and Infectious Diseases (NIAID), part of the National ... Rochester, NY, Baltimore and Los Angeles will enroll a ... part of the NIAID-sponsored Vaccine and Treatment Evaluation Units ...
... remains a challenging problem. Building classifiers based on ... the selection of non-redundant but relevant genes is ... enough to allow diagnosis even in regular clinical ... regulatory pathways. Here an entropy-based method is proposed ...
... rate of HIV infection, warn two senior doctors in an ... people worldwide, including over 2 million children, are now infected ... 2003. , The underlying reason for this continuing increase is ... write the authors. , For instance, the search for a ...
Cached Biology News:NIAID Initiates Trial of Experimental Avian Flu Vaccine 2
(Date:9/2/2015)... TEL-AVIV, Israel , September 2, 2015 /PRNewswire/ ... BLGTY, TASE: BOLT) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, announced today ... treatment of glaucoma will be delivered at the ... of the European Society of Cataract & Refractive ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... members will be attending Pharma Ed Resources upcoming educational seminar and training ... industry leading speakers, this timely conference will provide Updates & Case Studies on ...
(Date:9/1/2015)... , September 2, 2015 ... auf die Forschung und Entwicklung neuartiger Therapien ... chronisch-entzündliche Darmerkrankungen und Reizdarm konzentriert, erhält vom ... dass sein neues Medikament patentiert wird. Das ... Allergien bei Kindern verhindert und Entzündungen vorbeugt.   ...
(Date:9/1/2015)... 1, 2015 Prostate cancer is ... American men. One in seven men will be ... cases are diagnosed annually. That said, not every ... powerful new technique, MRI Fusion Biopsy, to more ... treating only the affected areas and monitoring ...
Breaking Biology Technology:Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4
... CryoLife, Inc., (NYSE: CRY ) ... today announced,that it has received 510(k) clearance ... its CryoValve(R) SG pulmonary human heart valve ... proprietary,SynerGraft technology is designed to remove allogeneic ...
... CHENGDU, China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Inc., ... modernized traditional Chinese medicine (TCM) based in Chengdu,China, ... of the Board of,Directors, will host a conference ... financial results., The conference call will take ...
... Feb 7 Dilon Technologies, makers of,a gamma imaging ... G. Moussa to the position of President and Chief ... in the medical device industry,having held a number of ... -- a health care corporation he ran as,CEO for ...
Cached Biology Technology:CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 2CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 3Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST 2Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ' ... Major Weapon in the Battle Against Cancer' 2
... loci identification through targeting resequencing. ... intensive assay validation/optimization, high throughput PCR ... customer-supplied samples and sequence alignment and ... rapid and highly accurate identification of ...
... Luciferase-based ENGENISTM (Entire Gene/cDNA or Isolated Sequence) ... a quantitative approach for evaluation of a ... as an efficient target for RNA interference ... are not perfect, leaving the probability of ...
... Stabilizer is a is a bovine protein-free ... product is an aqueous solution that contains ... buffered saline), pH 6.6 - 7.2. ... methylisothiazolone and 0.02% bromonitrodioxane as a preservative. ...
... Mouse anti-Yersinia pestis F1 antigen, ... Applications: ELISA: Use at ... at an assay dependent dilution. WB: ... Predicted molecular weight: 18 kDa. Not ...
Biology Products: